DHHB Formulation Guide: Avobenzone Photostabilisation & UVA Coverage | Onerchem
◆ UV Filters
DHHB Formulation Guide: Avobenzone Photostabilisation, Triplet Quenching & Regulatory Limits
DHHB is the only UV filter available in the EU that simultaneously acts as a primary UVA absorber and a photostabiliser for Avobenzone. This guide covers the triplet quenching mechanism that makes the system work, the oil-phase dissolution requirements that make it fail if ignored, EU regulatory limits, and how to validate photostability against the ISO 24443 standard.
What is DHHB — and why it does two jobs at once
DHHB (Diethylamino Hydroxybenzoyl Hexyl Benzoate, CAS 302776-68-7) is an oil-soluble UV filter developed by BASF and marketed under the trade name Uvinul A Plus. It is approved in the EU under Regulation (EC) No 1223/2009, Annex VI at a maximum concentration of 10% in finished products.
What makes DHHB commercially valuable is that it performs two distinct functions in a sunscreen formula — functions that would otherwise require two separate ingredients:
- Primary UVA filter — DHHB absorbs UV radiation across approximately 310–400nm, providing broad UVA-I and UVA-II coverage. At 6%, it contributes meaningfully to the formula's overall UVA protection factor, independent of its photostabilisation role.
- Avobenzone photostabiliser — DHHB accepts excitation energy from Avobenzone's excited triplet state via Dexter-type energy transfer, preventing the irreversible structural rearrangement that causes Avobenzone to lose its UV-absorbing capacity under sustained UV exposure.
No other UV filter currently approved in the EU combines both of these functions in a single molecule at comparable efficiency. This dual functionality makes DHHB the default choice for Avobenzone photostabilisation in EU-market hybrid sunscreen formulas.
The triplet quenching mechanism — why molecular proximity is mandatory
Understanding the photostabilisation mechanism is essential for understanding why the formulation constraints exist. The mechanism is not intuitive — it is a quantum-level energy transfer process, and its distance dependence is the reason why oil-phase co-dissolution of DHHB and Avobenzone is a non-negotiable formulation requirement.
Step 01
Avobenzone absorbs UVA photon
Avobenzone in its enol form absorbs a UVA-I photon, reaching an excited singlet state (S₁). Rapid intersystem crossing converts this to the excited triplet state (T₁).
→
Step 02 — DHHB intercepts
Dexter-type triplet energy transfer
At near-molecular-contact distance, DHHB accepts the triplet excitation energy from Avobenzone via Dexter mechanism — requiring orbital overlap between the two molecules.
→
Step 03
Avobenzone returns to ground state intact
With the triplet energy transferred to DHHB (which dissipates it safely as heat), Avobenzone returns to its enol ground state without undergoing the keto-form rearrangement. The cycle repeats.
Why Distance Matters
Dexter-type energy transfer has an exponential distance dependence — it drops off extremely rapidly beyond a few angstroms of molecular separation. This is fundamentally different from Förster (FRET) energy transfer, which operates at longer distances. For Dexter transfer to occur between DHHB and Avobenzone, the molecules must be in close physical proximity — which is only possible when both are dissolved in the same continuous phase. An Avobenzone molecule in an aqueous droplet and a DHHB molecule in an oil droplet are physically separated by a phase boundary: no Dexter transfer, no photostabilisation.
The photostabilisation mechanism is not chemistry — it is physics. It operates at near-contact molecular distances. Dissolving DHHB and Avobenzone in the same oil phase is not a formulation preference; it is the prerequisite for the mechanism to function at all.
DHHB vs Octocrylene — choosing the right photostabiliser for your market
Both DHHB and Octocrylene photostabilise Avobenzone via triplet quenching, but they differ significantly in their secondary functions and market approvals. The choice between them is primarily determined by your target market.
| Attribute | DHHB (Uvinul A Plus) | Octocrylene |
|---|---|---|
| Photostabilisation mechanism | Dexter triplet quenching — same mechanism as Octocrylene | Dexter triplet quenching — effective photostabiliser |
| Primary UV absorption | UVA broad 310–400nm — meaningful UVA contribution UVA Filter | UVB/UVA-II 280–320nm — limited UVA-I contribution UVB Focus |
| EU approval | Approved Annex VI, max 10% Source ↗ | Approved Annex VI, max 10% |
| US FDA OTC monograph | Not approved — not in 21 CFR Part 352 | Approved — included in FDA OTC monograph at up to 10% |
| Benzophenone concern | No benzophenone structure | Benzophenone-related structure — some consumer-facing concern in clean beauty positioning |
| Best market fit | EU, GCC, Australia, Asia — premium broad-spectrum formulas | US market — or any market where Octocrylene's FDA status is required |
US Market Note
DHHB is not in the US FDA OTC sunscreen monograph and cannot be used as a sunscreen active in US OTC sunscreen products. For formulas intended for both US and EU markets, separate formulations are typically required — DHHB-based for EU/GCC/Asia, Octocrylene-based for US.
Regulatory status — EU Annex VI and key market approvals
| Market | Status | Max Concentration | Reference |
|---|---|---|---|
| European Union | Approved | 10% in finished product | EC 1223/2009, Annex VI ↗ |
| China (NMPA) | Approved | 10% | China IECIC UV filter list |
| Australia (TGA) | Approved | 10% | TGA Sunscreen Standard |
| GCC Markets | Approved | Follows EU limits in most GCC markets | GCC Technical Regulation on Cosmetics |
| United States (FDA) | Not approved | N/A — not in OTC monograph | 21 CFR Part 352 ↗ |
Formulation requirements — what the mechanism demands
Oil phase dissolution — the non-negotiable step
- Dissolve DHHB and Avobenzone together in the oil phase at 70–75°C — Both are solid or semi-solid at room temperature. Heat the oil emollient fraction (Caprylic/Capric Triglyceride, Dicaprylyl Carbonate, or similar) to 70–75°C, then add DHHB and Avobenzone. Stir until both are fully and clearly dissolved before proceeding to emulsification. Undissolved crystals of either filter are visible under magnification and indicate an incomplete dissolution step.
- Confirm complete dissolution visually before emulsification — The oil phase containing dissolved DHHB and Avobenzone should appear clear to very slightly yellow — no visible particles or haziness from undissolved filter. If haziness persists at 70–75°C, the oil phase may have insufficient solvency capacity for the filter load. Increase the proportion of polar emollient esters (Caprylic/Capric Triglyceride, Isopropyl Myristate) or reduce the total UV filter concentration.
- Maintain both filters in the same continuous oil phase through emulsification — Add Phase B (oil + UV filters) to Phase A (water phase) under high-shear mixing at 70–75°C. Once emulsified, the UV filters are distributed throughout the dispersed oil droplets — molecular proximity is maintained within each droplet.
- Typical use ratio: 6% DHHB + 3% Avobenzone — This ratio is commonly referenced in formulation literature as providing effective photostabilisation. The photostability outcome must be validated by ISO 24443 testing for each specific formula — the ratio alone does not guarantee photostability across all formula architectures. Based on published cosmetic formulation data; not a validated claim for any specific finished product.
Oil phase solvency
DHHB requires adequate oil-phase solvency for complete dissolution. Polar emollient esters (Caprylic/Capric Triglyceride, Dicaprylyl Carbonate, Isopropyl Myristate, C12-15 Alkyl Benzoate) provide better solvency than non-polar oils (mineral oil, silicones). A minimum oil phase of approximately 15–20% of the total formula weight is generally required to dissolve a combined UV filter load of 6% DHHB + 3% Avobenzone, though this depends on the specific emollient composition.
Product Page · UV Filters
DHHB (CAS 302776-68-7) — HPLC ≥98%, EU Annex VI compliant, batch COA included
View Product
→
Photostability validation — ISO 24443 and what to look for
A formula containing DHHB + Avobenzone must be validated for photostability before launch. The standard method is ISO 24443 (Determination of photoprotection of sunscreen products in vitro), which measures UV absorbance before and after a defined UV irradiation protocol.
What ISO 24443 measures
The test applies a defined UV irradiation dose to a thin film of the finished formula on a substrate. UV absorbance is measured before and after irradiation across the UV spectrum. The ratio of post-irradiation to pre-irradiation absorbance at 360nm — the peak of Avobenzone's UVA-I absorption — is the photostability metric.
Photostability Target
A DHHB + Avobenzone system is considered photostable when post-irradiation absorbance at 360nm retains at least 90% of the pre-irradiation value under the ISO 24443 protocol. This 90% retention threshold is referenced in EU cosmetics industry guidance as the benchmark for a photostable Avobenzone system. Note: this is an industry benchmark referenced in guidance documents, not a legally mandated threshold under EU Regulation (EC) No 1223/2009. Each formula must be tested individually — the photostability performance varies with emulsion architecture, emulsifier system, and total oil phase composition.
Factors that affect photostability performance
- Oil phase polarity — Polar emollient esters (Caprylic/Capric Triglyceride, Isopropyl Myristate) support better UV filter dissolution and distribution, generally correlating with better photostability performance than non-polar systems.
- Emulsion droplet size — Smaller, more uniform oil droplets produced by high-shear homogenisation increase the surface area for UV filter distribution and generally improve photostability performance vs coarser emulsions.
- Mineral UV filters — coated grade only — Uncoated TiO₂ generates hydroxyl radicals under UV irradiation that degrade Avobenzone, undermining photostability regardless of DHHB concentration. Only coated mineral filters (alumina/dimethicone coated TiO₂ or ZnO) are compatible with Avobenzone-containing formulas. Confirm coating specification on the mineral filter COA.
- Antioxidant load — High concentrations of reducing antioxidants (L-Ascorbic Acid, high-dose Alpha Lipoic Acid) in the same oil phase may interfere with the triplet quenching mechanism. Tocopherol at standard cosmetic use levels (0.2–0.5%) is compatible and beneficial.
Critical incompatibilities
- Uncoated TiO₂ or ZnO — Uncoated mineral UV filters are photocatalytic under UV irradiation, generating hydroxyl radicals that degrade Avobenzone at rates that overwhelm DHHB's photostabilisation capacity. Always specify coated mineral filter grades and confirm the coating type on the COA. This is the most common cause of photostability failure in hybrid formulas that test well on paper but fail ISO 24443.
- Separation of DHHB and Avobenzone into different phases — Any formulation approach that places DHHB and Avobenzone in different phases eliminates the photostabilisation mechanism. Both must be co-dissolved in the same continuous oil phase. This includes approaches where one filter is in a pre-emulsified dispersion and the other is dissolved in the bulk oil phase — the phase boundary between the dispersion and the bulk oil limits molecular contact.
- Anionic emulsifiers at high concentrations near mineral filters — High concentrations of anionic emulsifiers can interact with the surface coatings of mineral UV filters, reducing their photocatalytic passivation. Use non-ionic emulsifier systems (Glyceryl Stearate SE, Cetearyl Glucoside, Ceteareth-based systems) in hybrid formulas containing both mineral and organic filters.
- pH below 4.0 in the finished formula — While DHHB itself is chemically stable across a wide pH range, very low pH formulas are uncommon in sunscreen applications and may affect the overall emulsion stability and UV filter distribution. Standard sunscreen formulas are typically pH 5.5–7.0.
Frequently asked questions
DHHB (Diethylamino Hydroxybenzoyl Hexyl Benzoate, CAS 302776-68-7, trade name Uvinul A Plus) is an EU-approved UV filter serving two functions: a primary UVA absorber across 310–400nm, and a photostabiliser for Avobenzone via Dexter-type triplet energy transfer. It is approved at up to 10% in the EU under Regulation (EC) No 1223/2009, Annex VI. It is not approved in the US FDA OTC sunscreen monograph.
The Dexter-type triplet energy transfer mechanism that allows DHHB to photostabilise Avobenzone operates at near-molecular-contact distances — it requires physical proximity between the two molecules. Both must be dissolved in the same continuous oil phase. If separated into different phases, the energy transfer does not occur and Avobenzone degrades normally under UV exposure. This is a physical constraint of the mechanism, not a formulation preference.
10% in finished cosmetic products, per EU Regulation (EC) No 1223/2009, Annex VI. A typical Avobenzone photostabilisation system uses 6% DHHB + 3% Avobenzone — well within the limit. Source: EC 1223/2009, Annex VI.
No. DHHB is not in the US FDA OTC sunscreen monograph (21 CFR Part 352) and cannot be used as a sunscreen active in US OTC sunscreen products. For US market formulas, Octocrylene is the primary practical Avobenzone photostabiliser among FDA-approved actives. Formulators targeting both US and EU markets typically require separate formulations.
The standard validation method is ISO 24443 (in vitro photostability). The industry benchmark is ≥90% absorbance retention at 360nm after the standard irradiation protocol — referenced in EU cosmetics industry guidance as the threshold for a photostable Avobenzone system. This is an industry benchmark, not a legally mandated threshold under EU Regulation (EC) No 1223/2009. Each formula must be validated individually by ISO 24443 testing before launch.